ebook Munafa Stock Market Course + Intraday & FNO calls  

       

Novartis Ag (NVS) Technical (Analysis) Reports Novartis Ag ["Technical Analysis"] Reports -USA Stock Exchange MunafaSutra.com

Complete & easy to understand technical analysis of Novartis Ag (NVS)

Technical Analysis Report for USA stock NVS Novartis Ag. Dated: 15 Apr 2026 Updated Daily. Stock trades under Health Care Deals in Major Pharmaceuticals in USA stock exchange

If you are looking for Tomorrow's Movement Predictions for USA stock NVS Novartis Ag then click here. or read Experts views on Novartis Ag or Forecast & share price targets of Novartis Ag

Novartis Ag Opened at 153.98 and Closed at: 152.08, which is -0.85% of previous session's close. It moved within a range of 150.86 and 154.10
The session was a Bearish session with an average volume of 1097300, which is -14.55% of previous session's volumes.

  • Even though the stock has fallen, but its mid term trend is positive and in an uptrend.
  • Even though the stock has fallen, but its long term trend is positive and in an uptrend.

A Golden cross was found 5 days back on short term averages

Support for tomorrow is 149.85 and resistance for tomorrow is 153.09
These support and resistance points are valid for the first 5-15 minutes charts

Above are simple pivot point calculations. For a list of much stronger support and resistance levels click here. These are way more stronger support and resistance levels, and mark trend reversals and are Support & Resistance levels recommended by experts.

Support for tomorrow's hourly charts is 150.59, 149.11 resistance for tomorrow's hourly charts is 153.83, 155.59

10 Day SMA for Novartis Ag (NVS) is 153.66 and stock is trading below these levels. This is not a good sign for its short term trend

20 Day SMA for Novartis Ag (NVS) is 151.7 and the stock is trading above these levels. This is a good sign for its mid term trend

50 Day SMA for Novartis Ag (NVS) is 157.22 and the stock is trading below these levels. This is not a good sign for its mid to long term trend

100 Day SMA is 147.61 and the stock is trading above these levels. This is a good sign for its long term trend

200 Day SMA Novartis Ag is 135.93 and stock is trading above these levels. This is a good sign for its long term trend

20 DMA of Novartis Ag is at 151.7 and 200 DMA is at 135.93, while 50 DMA and 100 DMA are at 157.22 and 147.61 respectively

Novartis Ag (NVS) moving average of 20 SMA is at 151.7 and 20 EMA is at 153.52

Novartis Ag (NVS) moving average of 50 SMA is at 157.22 and 50 EMA is at 153.2

Novartis Ag (NVS) moving average of 100 SMA is at 147.61 and 100 EMA is at 148.11

Novartis Ag (NVS) moving average of 200 SMA is at 135.93 and 200 EMA is at 138.89

Laboratory Corporation has performed better than Novartis Ag in short term. You could have earned much better returns by investing in Laboratory Corporation, about 0.35% more returns!

Iqvia Holdings has performed better than Novartis Ag in short term. You could have earned much better returns by investing in Iqvia Holdings, about 7.53% more returns!

Humana Inc has performed better than Novartis Ag in short term. You could have earned much better returns by investing in Humana Inc, about 17.83% more returns!

Novartis Ag has performed better than Hca Healthcare in short term. Holding Novartis Ag could be a better choice for now!

Bio Techne has performed better than Novartis Ag in short term. You could have earned much better returns by investing in Bio Techne, about 16.34% more returns!

Supernus Pharmaceuticals has performed better than Novartis Ag in short term. You could have earned much better returns by investing in Supernus Pharmaceuticals, about 0.06% more returns!

Ultragenyx Pharmaceutical has performed better than Novartis Ag in short term. You could have earned much better returns by investing in Ultragenyx Pharmaceutical, about 18.36% more returns!

Ovid Therapeutics has performed better than Novartis Ag in short term. You could have earned much better returns by investing in Ovid Therapeutics, about 39.1% more returns!

Orthofix Medical has performed better than Novartis Ag in short term. You could have earned much better returns by investing in Orthofix Medical, about 8.77% more returns!

Atyr Pharma has performed better than Novartis Ag in short term. You could have earned much better returns by investing in Atyr Pharma, about 25.91% more returns!

Irhythm Technologies has performed better than Novartis Ag in short term. You could have earned much better returns by investing in Irhythm Technologies, about 7.64% more returns!

Novartis Ag has performed better than Iradimed Corporation in short term. Holding Novartis Ag could be a better choice for now!

Incyte Corporation has performed better than Novartis Ag in short term. You could have earned much better returns by investing in Incyte Corporation, about 4.85% more returns!

Novartis Ag has performed better than Icu Medical in short term. Holding Novartis Ag could be a better choice for now!

Cumberland Pharmaceuticals has performed better than Novartis Ag in short term. You could have earned much better returns by investing in Cumberland Pharmaceuticals, about 8.1% more returns!

Ascendis Pharma has performed better than Novartis Ag in short term. You could have earned much better returns by investing in Ascendis Pharma, about 7.78% more returns!

Novartis Ag has performed better than Arvinas Inc in short term. Holding Novartis Ag could be a better choice for now!

Novartis Ag Technical analysis of indicators

Price action analysis of Novartis Ag (NVS) based on a short term time period is negative, but trend is highly volatile. A longer duration price action analysis might give a better picture of the trend in this stock.

ADX buy sell signal for Novartis Ag stock for short term is SELL. Signal strength is Strong and stock is gaining momentum.

MACD generated a BUY signal for Novartis Ag in short term but the buy signal is initial and weak.

Novartis Ag Stock in short term is moving inside a range for now. Please check in a day or two to for a better buy sell signal. Bulls are getting tired and bears are picking up momentum.

Ichimoku cloud is of red color and prices are below the red cloud Prices appear to be coming down

CCI has generated a SELL signal for Novartis Ag in short term and SELL signal is strong!

RSI is generating a BUY signal in short term and the buying is gaining momentum.

MRSI is in negative zone. This is the SELL zone

Although the stock is in the SELL zone, but selling might be slowing down

Stock of Novartis Ag is picking up selling momentum according to indicator.

Volume based indicators are showing selling momentum.

Volume Weighted Averaged Price (VWAP) for short term is 153.75 and Novartis Ag NVS stock is trading below this level. This means that stock is falling with high volumes. VWAP is rising upwards.

People seem to be coming out and selling the Novartis Ag NVS stock. Volume based technical analysis of Novartis Ag NVS stock is negative.

Novartis Ag Stock has given negative returns over a short term period. Returns for a longer term period have been negative.

Force Index is moving in a negative zone, which indicates selling momentum for short term... Selling momentum is getting weaker.

Tomorrow's Predictions

You should also read Tomorrow's Movement Predictions for USA stock NVS Novartis Ag These predictions are based on various factors, are easy to understand, and upto 75% accurate!

And NVS Experts View which covers a lot of information including buying and selling signals

NVS future forecast & share price targets

You can also take a look at the Charts and indicator analysis here Announcements & NEWS by Novartis Ag or View Candle Stick Charts here

Chart Novartis Ag (NVS)  Technical (Analysis) Reports Novartis Ag [

Videos related to: Novartis Ag (NVS) Technical (Analysis) Reports Novartis Ag ["Technical Analysis"] Reports -USA Stock Exchange MunafaSutra.com

Hindi Basics How To Trade In FnO Futures Options Stock Market

Hindi Video The Truth Of Stock Markets That Everyone Is Hiding From You

Novartis Ag (NVS)  Technical (Analysis) Reports Novartis Ag [

 

Back to top